How to get Wegovy (injection and tablets)
Three percent of participants in the drugs pivotal trial reported hair loss (three times as many as those who used a placebo)
When activatedeither by your bodys own GLP-1 or by semaglutidethese receptors do several things: Lower blood glucose or blood sugar levels after a meal Slow gastric emptying, meaning you feel full faster Reduce hunger cues and appetite These three changes mean the drug can be an option to manage conditions related to blood glucose levels, like prediabetes and diabetes, and to help people lose weight
Trial STEP 3 (Wadden et al., JAMA 2021) Design Phase 3 / 68 weeks Population 611 adults with obesity + intensive behavior therapy Key result -16.0% body weight (2.4 mg) vs -5.7% placebo
As mentioned, semaglutide slows down digestion and increases feelings of fullness after eating, which results in the patient consuming less food, thus less calories, which drives weight loss
many patients achieve effective appetite control and weight loss at lower maintenance levels
